BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 28811300)

  • 1. Epigenetic regulation by the menin pathway.
    Feng Z; Ma J; Hua X
    Endocr Relat Cancer; 2017 Oct; 24(10):T147-T159. PubMed ID: 28811300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1.
    Dreijerink KMA; Timmers HTM; Brown M
    Endocr Relat Cancer; 2017 Oct; 24(10):T135-T145. PubMed ID: 28811299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
    Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
    Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome.
    Gurung B; Feng Z; Iwamoto DV; Thiel A; Jin G; Fan CM; Ng JM; Curran T; Hua X
    Cancer Res; 2013 Apr; 73(8):2650-8. PubMed ID: 23580576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation in the tumorigenesis of MEN1-associated endocrine cell types.
    Iyer S; Agarwal SK
    J Mol Endocrinol; 2018 Jul; 61(1):R13-R24. PubMed ID: 29615472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
    Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menin directly represses Gli1 expression independent of canonical Hedgehog signaling.
    Gurung B; Feng Z; Hua X
    Mol Cancer Res; 2013 Oct; 11(10):1215-22. PubMed ID: 23928057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-omics analyses of MEN1 missense mutations identify disruption of menin-MLL and menin-JunD interactions as critical requirements for molecular pathogenicity.
    Dreijerink KMA; Ozyerli-Goknar E; Koidl S; van der Lelij EJ; van den Heuvel P; Kooijman JJ; Biniossek ML; Rodenburg KW; Nizamuddin S; Timmers HTM
    Epigenetics Chromatin; 2022 Aug; 15(1):29. PubMed ID: 35941657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic epigenetic regulation by menin during pancreatic islet tumor formation.
    Lin W; Watanabe H; Peng S; Francis JM; Kaplan N; Pedamallu CS; Ramachandran A; Agoston A; Bass AJ; Meyerson M
    Mol Cancer Res; 2015 Apr; 13(4):689-98. PubMed ID: 25537453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menin: a scaffold protein that controls gene expression and cell signaling.
    Matkar S; Thiel A; Hua X
    Trends Biochem Sci; 2013 Aug; 38(8):394-402. PubMed ID: 23850066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.
    Wu X; Hua X
    Curr Mol Med; 2008 Dec; 8(8):805-15. PubMed ID: 19075677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menin mediates epigenetic regulation via histone H3 lysine 9 methylation.
    Yang YJ; Song TY; Park J; Lee J; Lim J; Jang H; Kim YN; Yang JH; Song Y; Choi A; Lee HY; Jo CH; Han JW; Kim ST; Youn HD; Cho EJ
    Cell Death Dis; 2013 Apr; 4(4):e583. PubMed ID: 23579270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: multiple endocrine neoplasia type 1, sporadic neuroendocrine tumors, and MENIN.
    Komminoth P
    Diagn Mol Pathol; 1999 Sep; 8(3):107-12. PubMed ID: 10565680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menin molecular interactions: insights into normal functions and tumorigenesis.
    Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ
    Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
    Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of the Scaffold Protein Menin and its Role in Hepatobiliary Pathology.
    Ehrlich L; Hall C; Meng F; Lairmore T; Alpini G; Glaser S
    Gene Expr; 2017 Jul; 17(3):251-263. PubMed ID: 28485270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of menin in neuroendocrine tumorigenesis.
    Lairmore TC; Chen H
    Adv Exp Med Biol; 2009; 668():87-95. PubMed ID: 20175456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Genetic Studies of Pancreatic Neuroendocrine Tumors: New Therapeutic Approaches.
    Stevenson M; Lines KE; Thakker RV
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):525-548. PubMed ID: 30098714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.
    Modali SD; Parekh VI; Kebebew E; Agarwal SK
    Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menin-mediated regulation of miRNA biogenesis uncovers the IRS2 pathway as a target for regulating pancreatic beta cells.
    Gurung B; Katona BW; Hua X
    Oncoscience; 2014; 1(9):562-6. PubMed ID: 25594065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.